Trial Profile
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled, Single Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of Single Oral Doses of VT-1598 in Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2023
Price :
$35
*
At a glance
- Drugs VT 1598 (Primary)
- Indications Coccidioidomycosis; Mycoses
- Focus Adverse reactions; First in man
- 28 Apr 2022 Status changed from recruiting to completed.
- 09 Dec 2021 Planned End Date changed from 29 Oct 2021 to 15 Dec 2021.
- 09 Dec 2021 Planned primary completion date changed from 29 Oct 2021 to 15 Dec 2021.